SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3vse'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EKJ_A_ACTA3003_0 (BETA-CARBONIC ANHYDRASE)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 8	TYR A 66 VAL A 63 HIS A 372 GLY A 17	None	0.91A	1ekjA-3vseA: 3.0 1ekjB-3vseA: 3.0	1ekjA-3vseA: 21.16 1ekjB-3vseA: 21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1K5Q_B_PACB559_0 (PENICILLIN G ACYLASE ALPHA SUBUNIT PENICILLIN G ACYLASE BETA SUBUNIT)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 7	ALA A 227 TYR A 185 SER A 234 ALA A 232	SAH A 401 ( 4.7A) None None None	0.94A	1k5qA-3vseA: undetectable 1k5qB-3vseA: undetectable	1k5qA-3vseA: 22.29 1k5qB-3vseA: 20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 12	GLU A 23 ARG A 55 ILE A 21 ILE A 40 TYR A 14	None	1.01A	1kijB-3vseA: undetectable	1kijB-3vseA: 23.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EJT_A_SAMA501_1 (N(2),N(2)-DIMETHYLGU ANOSINE TRNA METHYLTRANSFERASE)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ARG A 205 ASP A 243 ASP A 272	None SAH A 401 (-2.7A) SAH A 401 (-3.0A)	0.72A	2ejtA-3vseA: 14.3	2ejtA-3vseA: 24.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FK8_A_SAMA302_0 (METHOXY MYCOLIC ACID SYNTHASE 4)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 12	ILE A 21 GLY A 61 GLY A 54 LEU A 32 ALA A 51	None	0.98A	2fk8A-3vseA: 13.3	2fk8A-3vseA: 21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IGT_A_SAMA1001_1 (SAM DEPENDENT METHYLTRANSFERASE)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ASP A 243 ASP A 272 ASP A 293	SAH A 401 (-2.7A) SAH A 401 (-3.0A) SAH A 401 (-3.2A)	0.52A	2igtA-3vseA: 25.0	2igtA-3vseA: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IGT_B_SAMB1002_1 (SAM DEPENDENT METHYLTRANSFERASE)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ASP A 243 ASP A 272 ASP A 293	SAH A 401 (-2.7A) SAH A 401 (-3.0A) SAH A 401 (-3.2A)	0.58A	2igtB-3vseA: 24.8	2igtB-3vseA: 24.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2M2P_B_DHIB24_0 (INSULIN B CHAIN)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	TYR A 152 GLY A 164 PHE A 166	None	0.63A	2m2pB-3vseA: undetectable	2m2pB-3vseA: 8.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NYU_B_SAMB201_1 (PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 2)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 5	ALA A 227 ASP A 243 ASP A 272 ASP A 293	SAH A 401 ( 4.7A) SAH A 401 (-2.7A) SAH A 401 (-3.0A) SAH A 401 (-3.2A)	0.71A	2nyuB-3vseA: 14.9	2nyuB-3vseA: 16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q9R_A_BEZA203_0 (PROTEIN OF UNKNOWN FUNCTION)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 5	LEU A 314 GLY A 317 ILE A 290 ILE A 292	None	0.74A	2q9rA-3vseA: undetectable	2q9rA-3vseA: 20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DOU_A_SAMA1_1 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ASP A 243 ASP A 272 ASP A 293	SAH A 401 (-2.7A) SAH A 401 (-3.0A) SAH A 401 (-3.2A)	0.73A	3douA-3vseA: 13.8	3douA-3vseA: 17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM0_B_CHDB500_0 (ILEAL BILE ACID-BINDING PROTEIN)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 7	THR A 327 VAL A 291 THR A 289 VAL A 218	None	0.60A	3em0B-3vseA: undetectable	3em0B-3vseA: 17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PS9_A_SAMA670_0 (TRNA 5-METHYLAMINOMETHYL- 2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 12	PHE A 77 GLU A 106 GLY A 111 PHE A 134 GLY A 109	None	1.32A	3ps9A-3vseA: 3.6	3ps9A-3vseA: 19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V8V_A_SAMA802_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 9	PHE A 222 TYR A 224 ASP A 243 ASP A 272 PRO A 295	SAH A 401 (-4.3A) SAH A 401 (-4.8A) SAH A 401 (-2.7A) SAH A 401 (-3.0A) SAH A 401 ( 4.2A)	0.51A	3v8vA-3vseA: 15.9	3v8vA-3vseA: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V8V_B_SAMB802_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	6 / 12	ARG A 205 PHE A 222 TYR A 224 ASP A 272 ASP A 293 PRO A 295	None SAH A 401 (-4.3A) SAH A 401 (-4.8A) SAH A 401 (-3.0A) SAH A 401 (-3.2A) SAH A 401 ( 4.2A)	0.37A	3v8vB-3vseA: 31.3	3v8vB-3vseA: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AZS_A_SAMA1475_1 (METHYLTRANSFERASE WBDD)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ARG A 205 ASP A 116 GLN A 125	None	0.81A	4azsA-3vseA: 13.3	4azsA-3vseA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DF3_A_SAMA301_1 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	TYR A 118 THR A 195 GLU A 180	None	0.76A	4df3A-3vseA: 14.4	4df3A-3vseA: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DF3_B_SAMB301_1 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	TYR A 118 THR A 195 GLU A 180	None	0.77A	4df3B-3vseA: 14.3	4df3B-3vseA: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DMG_A_SAMA401_0 (PUTATIVE UNCHARACTERIZED PROTEIN TTHA1493)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 12	ARG A 205 TYR A 224 ASP A 243 ASP A 293 PRO A 295	None SAH A 401 (-4.8A) SAH A 401 (-2.7A) SAH A 401 (-3.2A) SAH A 401 ( 4.2A)	0.61A	4dmgA-3vseA: 39.6	4dmgA-3vseA: 27.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DMG_B_SAMB401_0 (PUTATIVE UNCHARACTERIZED PROTEIN TTHA1493)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 11	ARG A 205 TYR A 224 ASP A 243 ASP A 293 PRO A 295	None SAH A 401 (-4.8A) SAH A 401 (-2.7A) SAH A 401 (-3.2A) SAH A 401 ( 4.2A)	0.68A	4dmgB-3vseA: 39.8	4dmgB-3vseA: 27.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K39_A_SAMA504_0 (ANAEROBIC SULFATASE-MATURATING ENZYME)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 12	PHE A 256 GLU A 180 ASN A 181 ARG A 209 LEU A 208	None	1.42A	4k39A-3vseA: undetectable	4k39A-3vseA: 22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_A_ACTA502_0 (RNA POLYMERASE 3D-POL)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ARG A 209 LYS A 207 LYS A 206	None	1.26A	4k50A-3vseA: undetectable	4k50A-3vseA: 22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_E_ACTE502_0 (RNA POLYMERASE 3D-POL)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ARG A 209 LYS A 207 LYS A 206	None	1.26A	4k50E-3vseA: undetectable	4k50E-3vseA: 22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_I_ACTI506_0 (RNA POLYMERASE 3D-POL)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ARG A 209 LYS A 207 LYS A 206	None	1.25A	4k50I-3vseA: undetectable	4k50I-3vseA: 22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OU1_A_BEZA302_0 (RETRO-ALDOLASE, DESIGN RA114)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 8	TYR A 14 ILE A 26 ILE A 40 ALA A 51	None	0.97A	4ou1A-3vseA: undetectable	4ou1A-3vseA: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U15_A_0HKA2001_2 (MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARIN IC ACETYLCHOLINE RECEPTOR M3)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	ASN A 181 PHE A 100 TYR A 118	None	0.82A	4u15A-3vseA: undetectable	4u15A-3vseA: 23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 12	GLU A 23 ARG A 55 ILE A 21 ALA A 51 ILE A 40	None	0.93A	4uroC-3vseA: undetectable	4uroC-3vseA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LG3_I_Z80I401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 9	PHE A 15 VAL A 63 ASP A 25 ILE A 40	None	1.05A	5lg3I-3vseA: undetectable	5lg3I-3vseA: 22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M78_A_SALA304_1 (CARBONIC ANHYDRASE 2)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 7	PHE A 134 LEU A 64 THR A 65 THR A 50	None	0.88A	5m78A-3vseA: undetectable	5m78A-3vseA: 12.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NUN_A_Z80A201_1 (BETA-LACTOGLOBULIN)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	5 / 9	ALA A 137 ILE A 115 LEU A 113 ILE A 124 ILE A 151	None	1.00A	5nunA-3vseA: undetectable	5nunA-3vseA: 11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ODQ_A_ACTA703_0 (HETERODISULFIDE REDUCTASE, SUBUNIT A)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 6	ALA A 171 PRO A 172 PHE A 174 GLU A 190	None	1.32A	5odqA-3vseA: 3.3	5odqA-3vseA: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 6	ARG A 55 LEU A 60 PHE A 38 LEU A 32	None	1.15A	5x19P-3vseA: undetectable	5x19P-3vseA: 21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YW0_A_ACTA412_0 (UNCHARACTERIZED PROTEIN KDOO)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	3 / 3	LYS A 382 ASN A 333 SER A 296	None	1.15A	5yw0A-3vseA: undetectable	5yw0A-3vseA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_A_STIA603_1 (TYROSINE-PROTEIN KINASE ABL1)	3vse	PUTATIVE UNCHARACTERIZED PROTEIN (Staphylococcus aureus)	4 / 5	LEU A 339 ILE A 290 MET A 363 GLY A 364	None	1.05A	6hd6A-3vseA: undetectable	6hd6A-3vseA: 11.98

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EKJ_A_ACTA3003_0","BETA-CARBONIC ANHYDRASE","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"TYR A  66;VAL A  63;HIS A 372;GLY A  17","None","0.91A","1ekjA-3vseA:3.0;1ekjB-3vseA:3.0","1ekjA-3vseA:21.16;1ekjB-3vseA:21.16"],["1K5Q_B_PACB559_0","PENICILLIN G ACYLASE ALPHA SUBUNIT;PENICILLIN G ACYLASE BETA SUBUNIT","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"ALA A 227;TYR A 185;SER A 234;ALA A 232","SAH A 401 ( 4.7A);None;None;None","0.94A","1k5qA-3vseA:undetectable;1k5qB-3vseA:undetectable","1k5qA-3vseA:22.29;1k5qB-3vseA:20.07"],["1KIJ_B_NOVB444_1","DNA GYRASE SUBUNIT B","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"GLU A  23;ARG A  55;ILE A  21;ILE A  40;TYR A  14","None","1.01A","1kijB-3vseA:undetectable","1kijB-3vseA:23.73"],["2EJT_A_SAMA501_1","N(2),N(2)-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ARG A 205;ASP A 243;ASP A 272","None;SAH A 401 (-2.7A);SAH A 401 (-3.0A)","0.72A","2ejtA-3vseA:14.3","2ejtA-3vseA:24.89"],["2FK8_A_SAMA302_0","METHOXY MYCOLIC ACID SYNTHASE 4","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"ILE A  21;GLY A  61;GLY A  54;LEU A  32;ALA A  51","None","0.98A","2fk8A-3vseA:13.3","2fk8A-3vseA:21.31"],["2IGT_A_SAMA1001_1","SAM DEPENDENT METHYLTRANSFERASE","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ASP A 243;ASP A 272;ASP A 293","SAH A 401 (-2.7A);SAH A 401 (-3.0A);SAH A 401 (-3.2A)","0.52A","2igtA-3vseA:25.0","2igtA-3vseA:24.64"],["2IGT_B_SAMB1002_1","SAM DEPENDENT METHYLTRANSFERASE","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ASP A 243;ASP A 272;ASP A 293","SAH A 401 (-2.7A);SAH A 401 (-3.0A);SAH A 401 (-3.2A)","0.58A","2igtB-3vseA:24.8","2igtB-3vseA:24.64"],["2M2P_B_DHIB24_0","INSULIN B CHAIN","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"TYR A 152;GLY A 164;PHE A 166","None","0.63A","2m2pB-3vseA:undetectable","2m2pB-3vseA:8.06"],["2NYU_B_SAMB201_1","PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 2","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"ALA A 227;ASP A 243;ASP A 272;ASP A 293","SAH A 401 ( 4.7A);SAH A 401 (-2.7A);SAH A 401 (-3.0A);SAH A 401 (-3.2A)","0.71A","2nyuB-3vseA:14.9","2nyuB-3vseA:16.87"],["2Q9R_A_BEZA203_0","PROTEIN OF UNKNOWN FUNCTION","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"LEU A 314;GLY A 317;ILE A 290;ILE A 292","None","0.74A","2q9rA-3vseA:undetectable","2q9rA-3vseA:20.45"],["3DOU_A_SAMA1_1","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ASP A 243;ASP A 272;ASP A 293","SAH A 401 (-2.7A);SAH A 401 (-3.0A);SAH A 401 (-3.2A)","0.73A","3douA-3vseA:13.8","3douA-3vseA:17.33"],["3EM0_B_CHDB500_0","ILEAL BILE ACID-BINDING PROTEIN","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"THR A 327;VAL A 291;THR A 289;VAL A 218","None","0.60A","3em0B-3vseA:undetectable","3em0B-3vseA:17.74"],["3PS9_A_SAMA670_0","TRNA 5-METHYLAMINOMETHYL-2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"PHE A  77;GLU A 106;GLY A 111;PHE A 134;GLY A 109","None","1.32A","3ps9A-3vseA:3.6","3ps9A-3vseA:19.36"],["3V8V_A_SAMA802_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"PHE A 222;TYR A 224;ASP A 243;ASP A 272;PRO A 295","SAH A 401 (-4.3A);SAH A 401 (-4.8A);SAH A 401 (-2.7A);SAH A 401 (-3.0A);SAH A 401 ( 4.2A)","0.51A","3v8vA-3vseA:15.9","3v8vA-3vseA:20.85"],["3V8V_B_SAMB802_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",6,"ARG A 205;PHE A 222;TYR A 224;ASP A 272;ASP A 293;PRO A 295","None;SAH A 401 (-4.3A);SAH A 401 (-4.8A);SAH A 401 (-3.0A);SAH A 401 (-3.2A);SAH A 401 ( 4.2A)","0.37A","3v8vB-3vseA:31.3","3v8vB-3vseA:20.85"],["4AZS_A_SAMA1475_1","METHYLTRANSFERASE WBDD","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ARG A 205;ASP A 116;GLN A 125","None","0.81A","4azsA-3vseA:13.3","4azsA-3vseA:21.88"],["4DF3_A_SAMA301_1","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"TYR A 118;THR A 195;GLU A 180","None","0.76A","4df3A-3vseA:14.4","4df3A-3vseA:20.72"],["4DF3_B_SAMB301_1","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"TYR A 118;THR A 195;GLU A 180","None","0.77A","4df3B-3vseA:14.3","4df3B-3vseA:20.72"],["4DMG_A_SAMA401_0","PUTATIVE UNCHARACTERIZED PROTEIN TTHA1493","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"ARG A 205;TYR A 224;ASP A 243;ASP A 293;PRO A 295","None;SAH A 401 (-4.8A);SAH A 401 (-2.7A);SAH A 401 (-3.2A);SAH A 401 ( 4.2A)","0.61A","4dmgA-3vseA:39.6","4dmgA-3vseA:27.59"],["4DMG_B_SAMB401_0","PUTATIVE UNCHARACTERIZED PROTEIN TTHA1493","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"ARG A 205;TYR A 224;ASP A 243;ASP A 293;PRO A 295","None;SAH A 401 (-4.8A);SAH A 401 (-2.7A);SAH A 401 (-3.2A);SAH A 401 ( 4.2A)","0.68A","4dmgB-3vseA:39.8","4dmgB-3vseA:27.59"],["4K39_A_SAMA504_0","ANAEROBIC SULFATASE-MATURATING ENZYME","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"PHE A 256;GLU A 180;ASN A 181;ARG A 209;LEU A 208","None","1.42A","4k39A-3vseA:undetectable","4k39A-3vseA:22.77"],["4K50_A_ACTA502_0","RNA POLYMERASE 3D-POL","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ARG A 209;LYS A 207;LYS A 206","None","1.26A","4k50A-3vseA:undetectable","4k50A-3vseA:22.27"],["4K50_E_ACTE502_0","RNA POLYMERASE 3D-POL","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ARG A 209;LYS A 207;LYS A 206","None","1.26A","4k50E-3vseA:undetectable","4k50E-3vseA:22.27"],["4K50_I_ACTI506_0","RNA POLYMERASE 3D-POL","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ARG A 209;LYS A 207;LYS A 206","None","1.25A","4k50I-3vseA:undetectable","4k50I-3vseA:22.27"],["4OU1_A_BEZA302_0","RETRO-ALDOLASE, DESIGN RA114","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"TYR A  14;ILE A  26;ILE A  40;ALA A  51","None","0.97A","4ou1A-3vseA:undetectable","4ou1A-3vseA:21.55"],["4U15_A_0HKA2001_2","MUSCARINIC ACETYLCHOLINE RECEPTOR M3,LYSOZYME,MUSCARINIC ACETYLCHOLINE RECEPTOR M3","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"ASN A 181;PHE A 100;TYR A 118","None","0.82A","4u15A-3vseA:undetectable","4u15A-3vseA:23.32"],["4URO_C_NOVC2000_1","DNA GYRASE SUBUNIT B","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"GLU A  23;ARG A  55;ILE A  21;ALA A  51;ILE A  40","None","0.93A","4uroC-3vseA:undetectable","4uroC-3vseA:19.10"],["5LG3_I_Z80I401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"PHE A  15;VAL A  63;ASP A  25;ILE A  40","None","1.05A","5lg3I-3vseA:undetectable","5lg3I-3vseA:22.38"],["5M78_A_SALA304_1","CARBONIC ANHYDRASE 2","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"PHE A 134;LEU A  64;THR A  65;THR A  50","None","0.88A","5m78A-3vseA:undetectable","5m78A-3vseA:12.35"],["5NUN_A_Z80A201_1","BETA-LACTOGLOBULIN","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",5,"ALA A 137;ILE A 115;LEU A 113;ILE A 124;ILE A 151","None","1.00A","5nunA-3vseA:undetectable","5nunA-3vseA:11.75"],["5ODQ_A_ACTA703_0","HETERODISULFIDE REDUCTASE, SUBUNIT A","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"ALA A 171;PRO A 172;PHE A 174;GLU A 190","None","1.32A","5odqA-3vseA:3.3","5odqA-3vseA:21.07"],["5X19_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"ARG A  55;LEU A  60;PHE A  38;LEU A  32","None","1.15A","5x19P-3vseA:undetectable","5x19P-3vseA:21.26"],["5YW0_A_ACTA412_0","UNCHARACTERIZED PROTEIN KDOO","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",3,"LYS A 382;ASN A 333;SER A 296","None","1.15A","5yw0A-3vseA:undetectable","5yw0A-3vseA:25.24"],["6HD6_A_STIA603_1","TYROSINE-PROTEIN KINASE ABL1","3vse","PUTATIVE UNCHARACTERIZED PROTEIN","Staphylococcus aureus",4,"LEU A 339;ILE A 290;MET A 363;GLY A 364","None","1.05A","6hd6A-3vseA:undetectable","6hd6A-3vseA:11.98"]]